.
NYU Langone Health Update on Attention Deficit Hyperactivity Disorder Through the Lifespan 2024
Gain Cutting-Edge Insights on ADHD Diagnosis and Treatment
Learning Objectives:
- Discuss identification and treatment of reading and learning disorders in children with these disorders and ADHD
- Describe the high rates of overlap of substance use disorders and ADHD
- Revise their screening protocols for ADHD for females of all ages as discussed in pending guidelines for adult ADHD
- Screen their adult patients who have been diagnosed with depression for ADHD
- Evaluate their current practice regarding the relative safety and efficacy of the pharmacological treatment of adults with ADHD
- Discuss the most recent follow-up studies on persons with Long COVID investigating neurological, neuropsychological, and psychiatric symptoms relative to controls
- Discuss the impact that parental ADHD has on coping with ADHD in children in the family
Let’s take a look at the topics
1. Keynote Address: ADHD Diagnosis & Treatment Across the Lifespan
Speaker: Dr. Jeffrey Newcorn
- Overview of ADHD across childhood, adolescence, and adulthood.
- Diagnostic challenges, including the controversy over adult-onset ADHD.
- Current treatment landscape: Stimulants, non-stimulants, and emerging therapies.
- Long-term effects of untreated ADHD on academic, social, and occupational outcomes.
- Strategies for optimizing ADHD treatment to reduce impairment and comorbid conditions.
2. ADHD, Substance Use Disorders & Cannabis Use
Speaker: Dr. Mariely Hernandez
- ADHD significantly increases the risk of developing substance use disorders (SUDs).
- Cannabis is commonly used by ADHD patients for self-medication, especially for sleep issues.
- Cannabis use in ADHD patients is linked to worsened cognitive function and executive dysfunction.
- Challenges in co-treating ADHD & SUDs: balancing stimulant medication use and risk of diversion.
- Strategies for clinicians: Motivational interviewing, behavioral interventions, and alternative ADHD treatments.
3. ADHD & Depression
Speaker: Dr. Gregory Mattingly
- ADHD and depression frequently co-occur, with 4x higher risk of major depression in ADHD patients.
- Neurobiological overlap between ADHD and mood disorders.
- ADHD patients are more likely to have treatment-resistant depression.
- Treating ADHD improves depression outcomes, and combination treatment is often needed.
- Esketamine and bupropion-dextromethorphan as potential treatments for ADHD-related depression.
4. Implications of the Co-occurrence of ADHD and Learning Disabilities
Speaker: Dr. Erik Willcutt
- ADHD and learning disabilities (LDs) frequently co-exist.
- The role of executive function deficits in reading, writing, and math difficulties.
- Intervention strategies for clinicians, educators, and parents.
- Screening & assessment techniques to differentiate ADHD from primary learning disorders.
5. Parental ADHD & ADHD in the Family
Speaker: Dr. Andrea Chronis-Tuscano
- ADHD is highly heritable, and parental ADHD complicates child ADHD management.
- Parental ADHD affects parenting behaviors, making consistency and structure difficult.
- Effective interventions: Parent training, self-care strategies, and executive function coaching.
- Supporting families with ADHD: Educational resources, school collaboration, and family therapy.
6. The Possible Impact of Inflammation on ADHD Symptoms
Speaker: Dr. Richard Gallagher
- Emerging research suggests a link between neuroinflammation and ADHD.
- Post-viral syndromes, including Long COVID, may contribute to ADHD-like symptoms.
- Inflammation and brain function: How immune responses affect attention and executive function.
- Clinical implications: ADHD patients may be more vulnerable to neuroinflammatory conditions.
- Potential treatments: Anti-inflammatory interventions and further research into immune-modulating therapies.
7. ADHD Guidelines & Medication Shortage
Speaker: Dr. Lenard Adler
- Challenges in ADHD medication access due to supply chain issues and increased diagnoses.
- Alternatives to stimulant medications, including non-stimulants and behavioral interventions.
- Upcoming guidelines for ADHD in adults, including revised screening tools.
- Telehealth and ADHD medication prescribing: Benefits and risks.
- Long-term strategies for managing ADHD treatment gaps.
Who you will learn from
COURSE DIRECTORS |
Lenard A. Adler, MD Professor and Vice Chair for Education, Department of Psychiatry Director, Adult ADHD Program Professor, Department of Child & Adolescent Psychiatry NYU Grossman School of Medicine | Richard Gallagher, PhD Associate Professor, Departments of Child & Adolescent Psychiatry and Psychiatry Director, Organizational and Executive Function Treatment Program NYU Grossman School of Medicine |
GUEST SPEAKERS |
Andrea Chronis-Tuscano, PhD Joel and Kim Feller Endowed Professor of Psychology Department of Psychology University of Maryland College Park, MD | Mariely Hernandez, PhD Postdoctoral Research Fellow, Division on Substance Use Disorders Columbia University Medical Center New York, NY |
Gregory W. Mattingly, MD Associate Clinical Professor Department of Psychiatry Washington University School of Medicine St. Louis, MO | Jeffrey Newcorn, MD Professor of Psychiatry and Pediatrics Medical Director, Division of ADHD, Learning Disabilities and Related Disorders Director, Center for Excellence in ADHD and Related Disorders Icahn School of Medicine at Mount Sinai Program Director, Pediatric Psychopharmacololgy Mt. Sinai Health System New York, NY |
Erik Willcutt, PhD Professor, Dept. of Psychology and Neuroscience University of Colorado Boulder, CO |
Who Should Enroll in This Course?
This virtual ADHD course is designed for healthcare professionals, educators, and researchers looking to stay updated on cutting-edge ADHD diagnosis and treatment strategies.
👩⚕️ Healthcare Professionals
- Psychiatrists & Psychologists – Learn about latest ADHD treatments, comorbidities (SUDs, depression), and emerging research on neuroinflammation.
- Pediatricians & Neurologists – Gain insights into early ADHD diagnosis, medication management, and long-term outcomes.
- Primary Care Physicians – Improve ADHD screening and treatment approaches for both children and adults.
- Nurse Practitioners (NPs) & Physician Assistants (PAs) – Enhance your ADHD management strategies for different patient populations.
🧠 Mental Health & Behavioral Specialists
- Clinical Social Workers & Therapists – Understand behavioral therapy approaches and family interventions for ADHD.
- Addiction Counselors – Learn how ADHD increases substance use risks and best practices for co-treatment.
📚 Educators & Learning Specialists
- Special Education Teachers & School Counselors – Develop effective strategies to support students with ADHD & learning disabilities.
- School Psychologists – Improve diagnosis accuracy and intervention planning for ADHD students.
🔬 Researchers & Academics
- Neuroscientists & Cognitive Researchers – Explore the latest ADHD research, including genetics, inflammation, and neurodevelopmental factors.
- Medical & Psychology Students – Build foundational knowledge in ADHD diagnosis and treatment.
💡 Why You Should Attend?
✅ Stay ahead of new ADHD guidelines & treatment approaches.
✅ Gain practical strategies for ADHD diagnosis, medication use, and behavioral interventions.
✅ Connect with top experts in ADHD research and clinical practice.
Why This Course?
The ADHD Through the Lifespan Virtual Course 2024 is a must-attend event for clinicians, educators, and researchers looking to stay ahead in ADHD diagnosis, treatment, and emerging research. This comprehensive, expert-led program provides practical tools and the latest scientific insights to enhance your professional expertise.
🚀 What Makes This Course Unique?
✅ Comprehensive Coverage – Learn about ADHD in children, adolescents, and adults, including comorbidities like depression, substance use disorders, and learning disabilities.
✅ Cutting-Edge Research – Discover the latest scientific breakthroughs, including neuroinflammation, ADHD & Long COVID, and genetic risk factors.
✅ Practical Treatment Strategies – Gain evidence-based tools to optimize ADHD diagnosis, medication management, and non-pharmacological interventions.
✅ Expert-Led Discussions – Learn from renowned ADHD specialists with decades of research and clinical experience.
✅ Live Q&A & Ask the Experts Panel – Engage in interactive discussions with experts, ask real-world clinical questions, and get actionable insights.
✅ Adapt to New Guidelines & Medication Challenges – Stay updated on emerging ADHD guidelines, screening recommendations for females and adults, and alternatives amid the ADHD medication shortage.
✅ Flexible & Accessible Learning – Join virtually from anywhere with access to session recordings and materials after the event.
Trusted by Healthcare & Mental Health Professionals from all over the World
941 Participant
99% Positive rating
Our Happy Clients Say About Us
Don't Miss This Limited-Time Offer
BIG SALE
Get instant access for a special price- 7 hours of videos
- Full HD videos
- Lifetime access
- Save $645
23 reviews for NYU Langone Health Update on Attention Deficit Hyperactivity Disorder Through the Lifespan